Purdue-Affiliated Company Inks Research Agreement
(image courtesy of Purdue University)
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowA Purdue University-affiliated company is working to reduce mortality and morbidity resulting from injuries on the battlefield through the development of new life-saving strategies. OYE Therapeutics Inc., located in the Purdue Research Park, has entered into a Cooperative Research and Development Agreement with the Uniformed Services University of the Health Sciences.
Purdue says the partnership includes research to enhance acute pain control at the point of injury, cognitive processing, psychomotor resilience and mission capabilities. Capt. Dr. Arlene Hudson, chair of anesthesiology at USU, said the project seeks to address a medical gap in care and meet the unique demands of warfighters.”
USU is an institution within the U.S. Department of Defense and The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
“An aspect of this CRADA is to evaluate peer-reviewed medical literature to assess OYE’s drug product pipeline for potential in military medicine,” said Dr. Jong Lee, an assistant professor of anesthesiology at USU.
Purdue says the collaboration between USU and HJF has the potential to encompass future projects, with the ultimate goal of enabling drug development to save the lives of American military personnel and for civilian care.